Retinoblastoma (RB) is the most common malignant intraocular tumour in children and can present as unilateral or bilateral disease. Unilateral RB represents 60% of all cases and tend to present at a relatively advanced stage of RB. Unilateral RB in Malaysia has a one-year survival rate of 99.0% and five-year survival of 93.0%. Shorter lag time, longer duration of follow-up and compliance with follow-up are good prognostic factors for the survival of unilateral RB patients. It is essential to report the prognostic factors associated with unilateral RB in our population. This information will assist healthcare professionals in understanding the factors that influence outcomes and support the development of long-term treatment guideline.
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.